FFAGLDD (TFA)

FFAGLDD (TFA)

• UNSPSC Description: FFAGLDD TFA is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release[1].
• Target Antigen: MMP
• Type: Peptides
• Related Pathways: Metabolic Enzyme/Protease
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/ffagldd-tfa.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CC=CC=C2)N.OC(C(F)(F)F)=O
• Molecular Weight: 897.85
• References & Citations: [1]Zhou Q, et al. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine. 2018 May 18;13:2921-2942.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported